Schedule 13G ownership disclosure

ESSA PHARMA INC

Common Shares, no par value per share (the "Shares") · CUSIP: 29668H708

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • PFM Health Sciences, LP

    Shares: 0.00 · Class: 0%

  • PFM Health Sciences GP, LLC

    Shares: 0.00 · Class: 0%

  • Partner Asset Management, LLC

    Shares: 0.00 · Class: 0%

  • Brian D. Grossman

    Shares: 0.00 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-014057
Form type
SCHEDULE 13G/A
Filer
ESSA Pharma Inc.
CIK
CIK 1633932
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub